Cargando…

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens

Detalles Bibliográficos
Autores principales:	Andeen, Nicole K., Smith, Kelly D., Vasilescu, Elena-Rodica, Batal, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403541/ https://www.ncbi.nlm.nih.gov/pubmed/32775835 http://dx.doi.org/10.1016/j.ekir.2020.05.010

Ejemplares similares

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
por: El Ters, Mireille, et al.
Publicado: (2020)

The Authors Reply
por: Andeen, Nicole K., et al.
Publicado: (2020)

DNAJB9 Is Not Transcriptionally Upregulated in the Glomerulus in Fibrillary Glomerulonephritis
por: Avasare, Rupali S., et al.
Publicado: (2019)

The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
por: Batal, Ibrahim, et al.
Publicado: (2023)

Familial Fibrillary Glomerulonephritis in Living Related Kidney Transplantation
por: Jeyabalan, Anushya, et al.
Publicado: (2020)

The Association Between Post–Kidney Transplant De Novo Glomerulonephritis and Alloimmunity
por: Khairallah, Pascale, et al.
Publicado: (2021)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response
por: Andeen, Nicole K., et al.
Publicado: (2022)

The Relationship between HLA-B27, HLA-Cw06, HLA-DR7 and Psoriatic Arthritis in Vietnamese Patients: Disease Progression and Therapeutic Burden
por: Minh, Vinh Ngo, et al.
Publicado: (2019)

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017)

Fibrillary Glomerulonephritis: An Update
por: Rosenstock, Jordan L., et al.
Publicado: (2019)

A Case of Fibrillary Glomerulonephritis
por: Venkataraj, Maamannan, et al.
Publicado: (2022)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

A Case of Posttransplant Fibrillary Glomerulonephritis
por: Ammayappan, Shiva Kumar, et al.
Publicado: (2023)

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

Fibrillary Glomerulonephritis with Crescentic and Necrotizing Glomerulonephritis and Concurrent Thrombotic Microangiopathy
por: Tsui, Calvin, et al.
Publicado: (2018)

Fibrillary Glomerulonephritis: A Great Mimicker of Rapidly Progressive Glomerulonephritis
por: Raikar, Manisha, et al.
Publicado: (2022)

Expression of HLA-DR antigen in large bowel carcinoma.
por: Chang, E. S., et al.
Publicado: (1995)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

Human hematopoietic progenitor cells in long-term cultures express HLA- DR antigens and lack HLA-DQ antigens
Publicado: (1985)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA- D/DR antigens
Publicado: (1983)

Fibrillary Glomerulonephritis in a Patient with Sjogren’s Syndrome
por: Lodhi, Muhammad Uzair, et al.
Publicado: (2018)

Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease
Publicado: (1984)

HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients
por: Lee, Myung Shik, et al.
Publicado: (1988)

HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy
por: Jin, B., et al.
Publicado: (2016)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Iizuka, N, et al.
Publicado: (2004)

Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
por: Leibler, Claire, et al.
Publicado: (2018)

Fibrillary glomerulonephritis: presenting as crescentic glomerulonephritis causing rapidly progressive renal failure
por: Nilajgi, Shalini, et al.
Publicado: (2011)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

The HLA-DRα Chain Is Modified by Polyubiquitination
por: Lapaque, Nicolas, et al.
Publicado: (2009)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996)

Human fibroblasts in idiopathic retroperitoneal fibrosis express HLA-DR antigens.
por: Lee, I.
Publicado: (1991)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
por: Szeto, Christopher, et al.
Publicado: (2020)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Treatment of fibrillary glomerulonephritis with use of repository corticotropin injections
por: Maroz, Natallia, et al.
Publicado: (2018)

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
por: Da, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ci27h2sa6ffg2l22f9ul6fjkf2